Skip to main content
Expand main menu
Close main menu
FSD Pharma inks deal with Covar for development of Lucid-PSYCH
FSD Pharma has entered into an agreement with Covar Pharmaceuticals to commence work on providing research quantities of FSD’s drug candidate, Lucid-PSYCH.
Ascendis Pharma intros Skytrofa
Skytrofa is the first and only FDA-approved, once-weekly treatment for pediatric growth hormone deficiency.
ChemoCentryx selects Amber Specialty Pharmacy to dispense Tavneos
Tavneos is used as an adjunctive treatment of adult patients with severe active ANCA-associated vasculitis, in combination with standard therapy.
Standout specialty services
Take a look at some innovative offerings from The Compliance Team, Knapp, LexisNexis Risk Solutions and Surescripts that are available to help specialty retailers.
Retailers bolster specialty pharmacy capabilities as its role in the industry grows
Specialty pharmacy provides customers with a wide range of services, including in-depth monitoring and patient counseling, as well as reimbursement assistance.
BioCareSD to provide 2 new specialty medications
Specialty distributor BioCareSD is offering Tepezza and Krystexxa, which offer treatment for thyroid eye disease and chronic gout, respectively.
Amber Specialty Pharmacy, Hy-Vee Pharmacy Solutions to provide Lilly’s COVID-19 antibody treatment
Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions have 21 locations licensed to administer the antibody treatment and serve patients in all 50 states and Puerto Rico.
Arcalyst, Gavreto available at AllianceRx Walgreens Prime
Two medicines prescribed for the treatment of specific kinds of cancer and an autoinflammatory cardiovascular disease are now available through AllianceRx Walgreens Prime.
WBA makes $970M majority investment in Shields Health Solutions
Walgreens Boots Alliance hopes to use the investment in the specialty pharmacy company as a means of speeding up the development of new healthcare models and creating a platform from which to build partnerships with health systems.
Hikma, FAES Farma ink licensing agreement for Bilastine
Hikma will be responsible for commercializing Bilastine once it is FDA approved.
Amber Specialty Pharmacy, Hy-Vee Pharmacy Solutions to administer Regeneron monoclonal antibody treatment
Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions have 21 locations in the United States and Puerto Rico that are licensed to administer Regeneron’s monoclonal antibody treatment.
Amber Specialty Pharmacy to dispense Kadmon’s Rezurock
Amber Specialty Pharmacy will support oncology and bone marrow transplant providers and patients throughout the country.
ParaPRO intros Natroba
ParaPro's Natroba is the first product for scabies to be approved by the Food and Drug Administration in more than 30 years.
Optum Frontier Therapies debuts in Las Vegas
Optum Frontier Therapies' flagship location will serve rare disease patients in all 50 states.